Clinical Trials Directory

Trials / Unknown

UnknownNCT01918969

Reference Values of Circulating Endothelial Progenitor Cells

Determination of Reference Values of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in a Blood Donnor Population

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Hopital Jean Minjoz · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- have been shown to be inversely correlated to aortic aneurysm size. However reference values have not yet been determined. This study is aimed to determine reference values of CD34+144+CD14- et CD34+VEGF-R2+CD14- in healthy men and women blood donors.

Detailed description

At the time of blood donation, 10mL of blood will be used to calculate the concentration of circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- , and the ratio of circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- / all circulating endothelial progenitor cells in order to determine reference values.

Conditions

Timeline

Start date
2013-10-01
Primary completion
2014-01-01
Completion
2014-03-01
First posted
2013-08-08
Last updated
2013-08-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01918969. Inclusion in this directory is not an endorsement.